# SciSparc

> SciSparc is a VC fund in Giv'atayim backing Pharmaceutical and Retail. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Giv'atayim, Israel
- Total investments: 4
- Last investment: Sep 2024
- Lead investor: 75%
- Last updated: Aug 2026
- Website: http://therapixbio.com/

SciSparc is a VC fund in Giv'atayim focused on Pharmaceutical and Retail. SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

## Contacts

5 contacts available for SciSparc. Shizune tracks 2 team members at SciSparc. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/therapix-biosciences?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Corporate Round | $400k–$700k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 2 | 50% |
| Retail | 1 | 25% |
| Cannabis | 1 | 25% |
| Biopharma | 1 | 25% |
| Automotive | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 1 | 25% |
| Post-IPO Debt | 1 | 25% |
| Corporate Round | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ari Aminetzah | CEO | 0 | https://shizune.co/investors/profile/ari-aminetzah |
| Adi Zuloff-Shani | CTO | 0 | https://shizune.co/investors/profile/adi-zuloff-shani-647b |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AutoMax Motors | AutoMax Motors is a vehicle importer company. It involved in the parallel importation and selling of various private automobile products. | $1.9M | Post-IPO Debt | Sep 11, 2024 |  |
| MitoCareX Bio | MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases. | $400K | Corporate Round | Feb 17, 2023 |  |
| MitoCareX Bio | MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases. | $700K | Corporate Round | Mar 31, 2022 |  |
| LaraPharm | LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed. | $1.5M |  | Apr 02, 2014 |  |

4 of 4 investments shown.

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Middle East](https://shizune.co/investors/biotechnology-investors-middle-east)
- [Biotechnology VC Funds in Middle East](https://shizune.co/investors/biotechnology-vc-funds-middle-east)
- [Health Care VC Funds in Israel](https://shizune.co/investors/health-care-vc-funds-israel)
- [Biotech Investors in Middle East](https://shizune.co/investors/biotech-investors-middle-east)
- [Biotech VC Funds in Middle East](https://shizune.co/investors/biotech-vc-funds-middle-east)
- [Biotech Investors in Israel](https://shizune.co/investors/biotech-investors-israel)

## FAQ

### What does SciSparc invest in?

SciSparc invests primarily in Pharmaceutical, Retail and Cannabis startups, most often at Funding Round and Post-IPO Debt stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is SciSparc's check size?

SciSparc typically joins rounds of $400k–$700k at Corporate Round. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SciSparc participates in.

### How do I contact SciSparc?

Public channels for SciSparc include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SciSparc?

The team at SciSparc includes Ari Aminetzah (CEO) and Adi Zuloff-Shani (CTO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co